Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Deborah S Bondi"'
Autor:
Deborah S. Bondi, Nicole M. Acquisto, Mitchell S. Buckley, Grace Erdman, Stefanie T. Kerns, Angela Shogbon Nwaesei, Thomas W. Szymanski, Autumn Walkerly, Adena S. Yau, Jay L. Martello
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6:427-439
Publikováno v:
J Pediatr Pharmacol Ther
We report on a premature neonate (31 4/7 weeks' gestation) who presented with hypercalcemia secondary to congenital mesoblastic nephroma (CMN), the most common type of renal tumor in neonates. Typical presentation includes a palpable abdominal mass o
Autor:
Genevra Galura, Sana J. Said, Pooja A. Shah, Alexandria M. Hissong, Nikunj K. Chokshi, Karen R. Fauman, Rebecca Rose, Deborah S. Bondi
Publikováno v:
J Pediatr Pharmacol Ther
OBJECTIVE To evaluate an institutional practice change from an extracorporeal life support (ECLS) anticoagulation monitoring strategy of activated clotting time (ACT) alone to a multimodal strategy including ACT, activated partial thrombin time, hepa
Autor:
Walid A. Hussain, Deborah S. Bondi, Pooja Shah, Sherwin E. Morgan, Sudhir Sriram, Michael D. Schreiber
Publikováno v:
J Pediatr Pharmacol Ther
OBJECTIVE Inhaled nitric oxide (iNO) is an effective but expensive treatment of pulmonary hypertension in newborns, with limited data regarding weaning. Our institution implemented a multidisciplinary iNO weaning protocol and stewardship to reduce in
Autor:
John M. Allen, Lisa M. Avery, Deborah S. Bondi, Sarah M. Michienzi, Jay L. Martello, Toby C. Trujillo, Emily Buatois, Joseph Ybarra, Allison M. Chung, Kathryn A Connor, Prasannaraddi Alavandi
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4:1594-1600
Publikováno v:
J Pediatr Pharmacol Ther
OBJECTIVES Guidelines by the AAP for the use of palivizumab prophylaxis for respiratory syncytial virus (RSV) recommend administration within 72 hours prior to discharge for selected high-risk patient populations. Our institution historically adminis
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3:764-770
Autor:
Michelle L. Rager, Deborah S. Bondi, Ann M. Philbrick, Margaret L. Hansen, Cynthia A. Jackevicius, Elizabeth F. Englin, Cara Nys, Paul M. Stranges, Christie Schumacher, Roshni P. Emmons, Sean Smithgall, Hanna Phan, Sarah L. Anderson, Ilya Danelich
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3:532-545
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 25:117-123
OBJECTIVES There is a national drug shortage of cefotaxime, and ceftazidime is recommended as an alternative to cefotaxime for neonates. This study evaluated culture-positive late-onset sepsis (LOS), multidrug resistant organisms (MDROs), and other n
Publikováno v:
J Pediatr Pharmacol Ther
OBJECTIVE Therapeutic hypothermia reduces the risk of death and major disability in neonates with moderate-to-severe hypoxic ischemic encephalopathy (HIE). Opioids and benzodiazepines are used to manage agitation but contribute to hemodynamic and res